ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing (2021)

First Author: Moore C

Attributed to: Paediatric and adolescent infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12879-020-05672-6

PubMed Identifier: 33446115

Publication URI: http://europepmc.org/abstract/MED/33446115

Type: Journal Article/Review

Parent Publication: BMC Infectious Diseases

Issue: 1

ISSN: 1471-2334